A detailed history of Fairfield Financial Advisors, LTD transactions in Abbott Laboratories stock. As of the latest transaction made, Fairfield Financial Advisors, LTD holds 22,809 shares of ABT stock, worth $2.69 Million. This represents 0.89% of its overall portfolio holdings.

Number of Shares
22,809
Previous 30,743 25.81%
Holding current value
$2.69 Million
Previous $3.19 Billion 18.59%
% of portfolio
0.89%
Previous 0.94%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$100.07 - $118.13 $793,955 - $937,243
-7,934 Reduced 25.81%
22,809 $2.6 Billion
Q2 2024

Aug 09, 2024

BUY
$100.73 - $112.44 $3.1 Million - $3.46 Million
30,743 New
30,743 $3.19 Billion
Q4 2023

Nov 04, 2024

SELL
$90.19 - $110.4 $699,152 - $855,820
-7,752 Reduced 14.72%
44,915 $4.94 Billion
Q3 2023

Nov 04, 2024

SELL
$95.53 - $114.62 $333,399 - $400,023
-3,490 Reduced 6.21%
52,667 $5.1 Billion
Q2 2023

Nov 04, 2024

BUY
$100.78 - $112.29 $3.36 Million - $3.74 Million
33,348 Added 146.21%
56,157 $6.12 Billion
Q1 2023

Nov 04, 2024

BUY
$96.86 - $114.01 $3.38 Million - $3.97 Million
34,854 Added 152.81%
57,663 $5.71 Billion
Q4 2022

Oct 07, 2024

SELL
$95.06 - $111.52 $371,969 - $436,377
-3,913 Reduced 6.23%
58,934 $6.47 Billion
Q3 2022

Oct 07, 2024

BUY
$96.76 - $112.03 $3.11 Million - $3.6 Million
32,104 Added 104.43%
62,847 $6.08 Billion
Q2 2022

Oct 07, 2024

BUY
$102.07 - $123.37 $3.27 Million - $3.95 Million
32,048 Added 104.24%
62,791 $6.82 Billion
Q1 2022

Oct 07, 2024

BUY
$114.02 - $139.04 $4.2 Million - $5.12 Million
36,836 Added 119.82%
67,579 $8 Billion

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Fairfield Financial Advisors, LTD Portfolio

Follow Fairfield Financial Advisors, LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fairfield Financial Advisors, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fairfield Financial Advisors, LTD with notifications on news.